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Galα1-­‐3Gal-­‐BSA	  
Isola/on	  of	  Glycoproteins	  in	  an	  Eppendorf	  	  using	  	  
	  
50	  µL	  RPL-­‐Sepharose	  –	  elu/on	  with	  sugar.	  
	  
Mixture	  of	  3	  Proteins	  (M)	  
(A)	   	  Asiaotransferrin	  –	  terminal	  β-­‐galactose.	  
	  
(R)	   	  Ribonuclease	  B	  –	  terminal	  mannose.	  
(G) 	  GFP	  –	  unglycosylated.	  
(1)	   	  RPL-­‐Gal1	  unbound	  frac/on 	  (2)	   	  Asialotransferrin	  extracted	  with	  RPL-­‐Gal1	  
(3)	   	  RPL-­‐αMan	  unbound	  frac/on 	  (4)	   	  Ribonuclease	  B	  extracted	  with	  RPL-­‐αMan	  	  
Galα1-­‐3Gal-­‐BSA	  
1 I r i s h 	   S e p a r a < o n 	   S c i e n c e 	   C l u s t e r , 	   N a < o n a l 	   C e n t r e 	   f o r 	   S e n s o r 	   R e s e a r c h , 	   D u b l i n 	   C i t y 	   U n i v e r s i t y , 	   I r e l a n d 	  
2 S c h o o l 	   o f 	   B i o t e c h n o l o g y , 	   D u b l i n 	   C i t y 	   U n i v e r s i t y , 	   I r e l a n d 	  
R ó i s í n  T h o m p s o n 1 ,  B r e n d a n  O ’ C o n n o r 2 ,  M i c h a e l  O ’ C o n n e l l 2  &  P a u l  C l a r k e 1  
	  Simple	  Scalable	  Produc<on	  of	  RPLs	  
	  
Introduc<on	  
More	  than	  50%	  of	  proteins	  are	  glycosylated	  and	  glycans	  are	  known	  to	  mediate	  a	  wide	  range	  of	  biological	  processes.	  With	  this	  knowledge,	  there	  has	  been	  an	  explosion	  
of	  interest	  in	  the	  ﬁeld	  of	  glycoproteomics.	  There	  is	  a	  need	  for	  tools	  that	  enable	  eﬃcient	  	  isola/on	  of	  glycoproteins	  from	  biological	  samples,	  where	  they	  are	  usually	  only	  
present	  at	  low	  levels,	  to	  enable	  their	  iden/ﬁca/on	  and	  analysis.	  Changes	  in	  glycosyla/on	  paTerns	  of	  biomolecules	  and	  cells	  are	  also	  associated	  with	  many	  diseases	  
such	  as	  cancer	  and	  rheumatoid	  arthri/s.	  Tools	  capable	  of	  sensi/ve	  detec/on	  of	  such	  changes	  would	  have	  signiﬁcant	  poten/al	  in	  the	  ﬁeld	  of	  diagnos/cs.	  In	  addi/on,	  
many	  biopharmaceu/cals	  are	  glycosylated	  and	  the	  glycosyla/on	  impacts	  their	  clinical	  proper/es.	  The	  industry	  needs	  tools	  	  for	  sensi/ve	  	  product	  analysis	  and	  selec/ve	  
puriﬁca/on	  of	  op/mally	  glycosylated	  product	  to	  meet	  regulatory	  requirements	  and	  to	  bring	  safer,	  more	  eﬀec/ve	  ,products	  to	  pa/ents.	  
	  
Recombinant	  Prokaryo/c	  Lec/ns	  (RPL’s)	  oﬀer	  new	  opportuni/es	  to	  develop	  enhanced	  glycoselec/ve	  tools	  for	  glycoprotein	  analysis	  and	  puriﬁca/on	  and	  to	  overcome	  
the	  limita/ons	  that	  	  have	  restricted	  the	  applica/ons	  of	  plant	  lec/ns.	  
	  
•  1	  mL	  &	  5	  mL	  Columns	  compa/ble	  with	  
LC	  systems	  (A).	  
	  
•  High	  RPL	  densi/es	  (~20	  mg.mL-­‐1).	  
•  High	  binding	  capacity	  (B).	  
•  RPL-­‐Gal1:	  24	  mg	  .mL-­‐1	  asialofetuin	  
•  ECL:	  	  10	  mg.mL-­‐1	  asialofetuin	  
•  Demonstrated	  reproducibility	  (C).	  
Simple	  Isola<on	  of	  Glycoproteins	  
	  
Enhanced	  Proper<es	  of	  RPL’s	  Compared	  to	  Commercial	  Bio<nylated	  Plant	  Lec<ns.	  
A.	   	  Enhanced	  Aﬃnity	  of	  RPL’s:	  	  
•  RPL-­‐Gal2	   shows	   3-­‐fold	   higher	   aﬃnity	   than	  
parental	  RPL-­‐αGal.	  	  
•  RPL-­‐Man1	   shows	   7	   fold	   higher	   aﬃnity	   than	  
parental	  RPL-­‐	  αMan	  
B.   Altered	  Speciﬁcity	  of	  RPL’s::	  	  
	   RPL-­‐Gal1	  displays	   strong	  binding	   to	  Galβ1-­‐4-­‐
linked	  sugars	  which	  parental	  RPL-­‐αGal	  cannot	  
bind.	  
C.	   	  Superior	  Aﬃnity	  to	  Plant	  Lec<ns:	  
•  RPL-­‐Gal2	   	  -­‐	  	  	  3	  fold	  higher	  than	  GSL-­‐I	  B4.	  
•  RPL-­‐Gal1	   	  -­‐	  	  	  5	  fold	  higher	  than	  ECL..	  
•  RPL-­‐Man1	   	  -­‐	  	  	  24	  fold	  higher	  than	  GNL.	  
D.	   	  Enhanced	  Detectability	  over	  Plant	  Lec<ns:.	  
•  Lower	  concentra/ons	  of	  RPL’s	  	  required.	  
•  Signiﬁcantly	  higher	  signal	  strength	  	  (3	  fold).	  
	  
A.	  Binding	  to	  Galα1-­‐3Gal-­‐BSA.	   B.	  Binding	  to	  Galβ1-­‐4GlcNAc-­‐BSA.	   C.	  Binding	  to	  Glucose	  Oxidase.	  
	  Frac<ona<on	  of	  Glycoprotein	  Glycoforms	  	  
	  
•  Separa/on	   of	   asialotransferrin	   &	  
transferrin	   	   using	   a	   1	   mL	   RPL-­‐Gal1	  
column.	  	  
•  Bound	   protein	   eluted	   with	   0.5	   M	  
galactose.	  	  	  
•  Conforma/on	  of	  separa/on	  by	  ELLA:	  
	  ECL	  and	  RPL-­‐Gal1	  only	  responded	  
	  to	  the	  eluted	  frac/on	  (insert).	  
	  
	  RPL-­‐Sepharoses:	  FPLC	  &	  HPLC	  Columns:	  	  	  	  
	  
•  High	  level	  of	  expression	  in	  E.	  coli	  
(Lane	  1).	  	  
•  Single	  step	  puriﬁca/on	  via	  IMAC.	  
•  High	  purity	  product	  (Lane	  4).	  
•  Scalable	  Produc/on	  -­‐	  1g	   from	  1L	  
culture.	  
•  Cost	  eﬀec/ve	  produc/on	  of	  large	  
quan//es	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